MEMED DIAGNOSTICS

Elevating Visibility with a Strategic Public Relations Approach

Diagnostics

Diagnostics

GOALS

MeMed Diagnostics, a global host-response diagnostics company, sought to amplify awareness of their MeMed Severity test after receiving the FDA’s Breakthrough Device Designation. Their goal was to communicate this milestone effectively to key stakeholders—customers, potential partners, and the media—ensuring a cohesive and consistent message.

The objective was to secure widespread media coverage in life sciences and diagnostics trade media, positioning MeMed as a leader in infection management solutions and helping to strengthen their competitive standing in the industry.

RESULTS

Our strategic approach delivered significant impact, with MeMed receiving:

  • 18 original articles in top-tier industry outlets
  • Widespread newswire pickup across business and finance-focused media
  • Placement of MeMed’s CEO on a key industry podcast to sustain visibility

SERVICES

Our comprehensive public relations services for MEMED  include:

  • Press release development and editing
  • Curating targeted media lists
  • Customized media pitch development
  • Embargoed media outreach and news distribution
  • Media relations and inquiry management
  • Coverage tracking, performance reporting, and article clipping

Public relations starts with powerful relationships

In public relations, success hinges on more than just timing and targeting—it’s about relationships and strategic messaging. At Brandwidth Solutions, we take a holistic approach, working as an extension of our client’s team to deliver meaningful results.

Our collaboration with MeMed demonstrates how a well-executed PR strategy can capture the attention of key audiences and drive meaningful engagement.

Our PR strategy at work

MeMed: Making Headlines with Strategic Media Outreach

MeMed’s FDA Breakthrough Device Designation for their MeMed Severity test was a critical milestone that needed maximum visibility. The test, which rapidly assesses a patient’s risk of deterioration from an acute infection, has the potential to transform emergency care.

While the news was significant, it needed to be communicated in a way that stood out in a crowded diagnostics landscape. Our goal was to position MeMed as a thought leader while ensuring their announcement reached the right audience at the right time.

Through a three-pronged approach, we maximized reach and impact:

  1. Embargoed Media Outreach:
    • Identified and engaged key reporters ahead of the announcement.
    • Provided an exclusive preview of the news under embargo, allowing journalists to prepare in-depth articles for launch day.
    • This led to original coverage in prominent outlets such as 360Dx, CAP Today, Contagion Live, FirstWord Healthtech, and Infectious Diseases Special Edition (IDSE).
  2. Wire Distribution:
    • Leveraged our relationship with Business Wire to distribute the release across key circuits, including North America’s Biosciences Corridor and VentureBeat, ensuring broad industry exposure.
    • The press release received more than 2600 views and over 400 link clicks, demonstrating strong engagement.
  3. Targeted Email Blast:
    • Delivered a highly personalized outreach campaign to over 100 industry-specific media outlets, driving additional coverage and expanding MeMed’s visibility within the diagnostics and life sciences sectors.

RESULTS

  • 18 original articles in top-tier industry publications:
    • 360Dx, CAP Today, Contagion Live, Clinical Lab Products, FirstWord Healthtech, G-Medtech, Infectious Diseases Special Edition (IDSE), Investors Hangout, LabPulse, Medical Design & Development, Medical Device and Diagnostic Industry (MD+DI), Medical Device Developments, Medical Device Network, Medical Laboratory Observer, Medical Product Outsourcing, Respiratory Therapy, and Xtalks
  • Pickup in many other relevant trade media magazines, including:
    • Asian Hospital & Healthcare Management, BioSpace, Boston Cambridge Biotech Networks, Laboratory Network, and Life Sciences Times
  • Significant traction in business and finance-focused outlets such as:
    • MarketWatch, VentureBeat, InvestorHub, Investors Hangout
  • Secured an exclusive podcast interview for MeMed’s CEO with Inside Precision Medicine, further solidifying their position as an industry leader.

Our efforts helped MeMed take considerable steps towards their goal of increased brand awareness, customer interest, and strategic partner engagement.

Our work with MeMed showcases how a thoughtful, strategic PR campaign can cut through the noise and achieve meaningful results. Whether it’s embargoed outreach, wire distribution, or targeted media engagement, we craft PR strategies that make an impact.

< PREVIOUS

NEXT >